MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center is one of the world’s most important oncology Centers of Excellence. Created in 1941 as part of The University of Texas System, MD Anderson became one of the original three comprehensive cancer centers designated under the U.S. National Cancer Act of 1971.
- Highest 2026 tier: Tier I
- Centers of Excellence
- 3 ranking categories
Overview
The University of Texas MD Anderson Cancer Center is one of the world’s most important oncology Centers of Excellence. Created in 1941 as part of The University of Texas System, MD Anderson became one of the original three comprehensive cancer centers designated under the U.S. National Cancer Act of 1971.
MD Anderson’s Center of Excellence profile is rooted in its full institutional focus on cancer. The center combines medical oncology, surgical oncology, radiation oncology, pathology, imaging, immunotherapy, genomics, prevention, clinical trials, and survivorship care within a disease-focused platform. This depth allows it to manage both common and rare cancers through specialized teams and research-driven treatment pathways.
MD Anderson Cancer Center is included in 3 2026 ranking categories. Its highest classification is Tier I. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.
Firm facts
| Public identity | MD Anderson Cancer Center |
| Founded | 1941 |
| Institution type | Centers of Excellence institution |
| Headquarters | Houston, United States |
| Primary focus | Centers of Excellence |
| Highest 2026 ranking tier | Tier I |
Principal activities
MD Anderson’s Center of Excellence profile is rooted in its full institutional focus on cancer. The center combines medical oncology, surgical oncology, radiation oncology, pathology, imaging, immunotherapy, genomics, prevention, clinical trials, and survivorship care within a disease-focused platform. This depth allows it to manage both common and rare cancers through specialized teams and research-driven treatment pathways.
Core capability
Centers of Excellence
Client relevance
Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.
Execution and verification
Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.
Sector and mandate coverage
Primary category
Centers of Excellence
Institutional context
Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.
Market position
MD Anderson’s combination of comprehensive cancer specialization, clinical trial infrastructure, translational research, multidisciplinary care, and global reputation supports its position as one of the leading Centers of Excellence in healthcare.
MD Anderson Cancer Center is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier I.
Competitive context
The relevant peer set varies by category, geography, client segment and mandate. MD Anderson Cancer Center should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.
Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.
Leadership and governance
Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.
Corporate and public information
The public-facing organization is identified here as MD Anderson Cancer Center. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.
Corporate and disclosure information
| Organization | MD Anderson Cancer Center |
| Headquarters | Houston, United States |
| Verification note | Confirm legal entity, licenses, offices and engagement terms directly before appointment or use. |
Rankings and recognition
Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:
- Healthcare Rankings and the New Economics of Expertise
- Healthcare Market Structure Is Opening a New Lane for Specialist Providers
- Healthcare Rankings and the New Geography of Distributed Care
Related institutions and subjects
Sources and data transparency
Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.
- Healthcare Ranking — Top 30 Centers of Excellence 2026 — 2026 inclusion and tier classification.
- Healthcare Ranking — Top 30 Specialty Hospitals 2026 — 2026 inclusion and tier classification.
- Healthcare Ranking — Top 30 Executive Health & Medical Concierge Programs 2026 — 2026 inclusion and tier classification.
- The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
- The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
- The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.
